Total Payments
$865.50
2024 Payments
$289.16
Companies
12
Transactions
20
Medicare Patients
868
Medicare Billing
$253,396
Payment Breakdown by Category
Food & Beverage$865.50 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $865.50 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Averitas Pharma Inc. | $135.96 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $132.09 | 2 | $0 (2024) |
| GENZYME CORPORATION | $121.83 | 1 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $119.51 | 1 | $0 (2019) |
| Merz Pharmaceuticals, LLC | $98.86 | 3 | $0 (2024) |
| Allergan Inc. | $72.14 | 3 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $63.77 | 1 | $0 (2023) |
| ABBVIE INC. | $39.98 | 2 | $0 (2023) |
| MERZ NORTH AMERICA, INC. | $28.59 | 1 | $0 (2020) |
| Metacel Pharmaceuticals LLC | $20.68 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $289.16 | 4 | GENZYME CORPORATION ($121.83) |
| 2023 | $276.87 | 7 | Averitas Pharma Inc. ($70.00) |
| 2022 | $47.14 | 2 | Merz Pharmaceuticals, LLC ($32.61) |
| 2020 | $28.59 | 1 | MERZ NORTH AMERICA, INC. ($28.59) |
| 2019 | $119.51 | 1 | ACADIA Pharmaceuticals Inc ($119.51) |
| 2017 | $104.23 | 5 | Allergan Inc. ($72.14) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $69.65 | General |
| Category: Gastroenterology | ||||||
| 09/03/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $65.96 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Immunology | ||||||
| 03/28/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $31.72 | General |
| Category: Musculoskeletal | ||||||
| 10/11/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Musculoskeletal | ||||||
| 09/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $62.44 | General |
| Category: Gastroenterology | ||||||
| 09/06/2023 | Collegium Pharmaceutical, Inc. | BELBUCA (Drug) | Food and Beverage | Cash or cash equivalent | $63.77 | General |
| Category: Opioid Analgesic | ||||||
| 09/06/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/05/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/09/2023 | Metacel Pharmaceuticals LLC | Ozobax (Drug) | Food and Beverage | Cash or cash equivalent | $20.68 | General |
| Category: Neurology | ||||||
| 05/01/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/25/2022 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: Musculoskeletal | ||||||
| 04/11/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/18/2020 | MERZ NORTH AMERICA, INC. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $28.59 | General |
| Category: MUSCULOSKELETAL | ||||||
| 07/26/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/19/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/03/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: ANTI-MIGRAINE | ||||||
| 09/21/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: ANTI-MIGRAINE | ||||||
| 06/22/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: OUD | ||||||
| 01/30/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 242 | 1,752 | $164,621 | $111,094 |
| 2022 | 5 | 252 | 999 | $104,118 | $64,651 |
| 2021 | 6 | 171 | 406 | $55,612 | $32,201 |
| 2020 | 6 | 203 | 589 | $78,248 | $45,449 |
Total Patients
868
Total Services
3,746
Medicare Billing
$253,396
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 145 | 1,539 | $140,049 | $95,928 | 68.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 54 | $8,640 | $5,715 | 66.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 43 | 82 | $7,462 | $5,185 | 69.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 77 | $8,470 | $4,266 | 50.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 127 | 733 | $66,703 | $43,001 | 64.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 148 | $16,280 | $8,994 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 85 | $13,600 | $8,864 | 65.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 22 | $3,300 | $1,928 | 58.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,235 | $1,863 | 44.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 49 | 152 | $13,832 | $8,924 | 64.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 92 | $13,800 | $8,129 | 58.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 61 | $9,535 | $6,421 | 67.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 65 | $7,150 | $3,996 | 55.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $6,545 | $2,912 | 44.5% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2021 | 16 | 19 | $4,750 | $1,819 | 38.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 55 | 298 | $27,118 | $17,959 | 66.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 45 | 135 | $20,250 | $12,315 | 60.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 28 | 28 | $10,780 | $4,947 | 45.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 33 | 62 | $6,820 | $3,929 | 57.6% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2020 | 31 | 38 | $9,500 | $3,723 | 39.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 28 | $3,780 | $2,576 | 68.1% |
About Dr. Venus Ramos, M.D
Dr. Venus Ramos, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679503940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Venus Ramos, M.D has received a total of $865.50 in payments from pharmaceutical and medical device companies, with $289.16 received in 2024. These payments were reported across 20 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($865.50).
As a Medicare-enrolled provider, Ramos has provided services to 868 Medicare beneficiaries, totaling 3,746 services with total Medicare billing of $253,396. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Long Beach, CA
- Active Since 07/03/2006
- Last Updated 08/07/2015
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1679503940
Products in Payments
- QUTENZA (Drug) $135.96
- RELISTOR (Drug) $132.09
- DUPIXENT (Biological) $121.83
- NUPLAZID (Drug) $119.51
- Xeomin (Biological) $98.86
- BELBUCA (Drug) $63.77
- BOTOX CHRONIC MIGRAINE (Drug) $47.82
- BOTOX (Biological) $39.98
- XEOMIN (Biological) $28.59
- BOTOX THERAPEUTIC (Biological) $24.32
- Ozobax (Drug) $20.68
- NUEDEXTA (Drug) $17.44
- SUBOXONE SUBLINGUAL FILM (Drug) $14.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Long Beach
Dr. Jason Koh, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $4,125
Physical Medicine & Rehabilitation $4,125
Kimberly Bedell, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,902
Physical Medicine & Rehabilitation $3,902
Nathaniel Dusto, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,987
Physical Medicine & Rehabilitation $1,987
Dr. Edward Barawid, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,739
Physical Medicine & Rehabilitation $1,739
Dr. Ronald Takemoto, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,457
Physical Medicine & Rehabilitation $1,457
Diemha Hoang, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,336
Physical Medicine & Rehabilitation $1,336